Alliance Boots today announces that it has completed the acquisition of a 12% stake in Nanjing Pharmaceutical Company Limited.
The completion follows receipt of government and regulatory approvals. As a result of the investment, Alliance Boots becomes the second largest shareholder of the company with the right to nominate Board members and a member of the senior management.
In September 2012, Alliance Boots announced its intention to invest in Nanjing Pharmaceutical Company Limited through a private placement, for a total consideration of approximately £56 million (RMB560 million).
Alliance Boots first entered the Chinese market in 2008 through its joint venture, Guangzhou Pharmaceuticals Corporation, which operates in complementary geographies and continues its successful development.
Download Nanjing - Full Completion - 4 Dec 2014
Download Nanjing - Full completion - 4 Dec 2014_Chinese
Comments